Saturday 17 October 2026
Export STE’s income statement to Excel — free account
STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
222.66
1.67
−0.74%
Follow STE
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
35.40 | 35.26 | 27.78 | 25.65 |
P/S ratio |
4.27 | 4.27 | 3.66 | 3.40 | |
P/FCF ratio |
25.09 | 26.58 | 22.09 | 21.96 | |
P/Operating CF |
84.60 | 83.49 | 64.74 | 55.98 | |
P/B ratio |
3.47 | 3.47 | 3.02 | 2.85 | |
Price to Tangible BV |
23.01 | 20.01 | 15.71 | 14.00 | |
EV/Sales |
4.57 | 4.55 | 3.91 | 3.64 | |
EV/EBITDA |
17.81 | 17.82 | 14.61 | 13.45 | |
EV/Operating CF |
20.02 | 20.92 | 17.30 | 17.05 | |
EV/FCF |
26.85 | 28.29 | 23.61 | 23.46 | |
Quick Ratio |
1.42 | 1.53 | 1.34 | 1.17 | |
Current Ratio |
2.37 | 2.48 | 2.09 | 1.91 | |
Net Debt/EBITDA |
4.07 | 3.73 | 3.39 | 3.44 | |
Debt/Assets |
18.22% | 17.92% | 17.99% | 17.64% | |
Debt/Equity |
0.27 | 0.26 | 0.27 | 0.26 | |
Asset Turnover |
0.55 | 0.57 | 0.57 | 0.57 | |
Operating CF/Net income |
1.50 | 1.55 | 1.52 | 1.83 | |
Capex/Depreciation |
(0.71) | (0.72) | (0.73) | (0.71) | |
Interest Coverage |
17.84 | 18.34 | 21.11 | 18.09 | |
Research and Development Expense of Revenue |
1.93% | 1.97% | 1.81% | 1.92% | |
Selling, General and Administrative Expense of Revenue |
23.95% | 23.55% | 22.16% | 24.77% | |
Intangible Assets out of Total Assets |
0.57 | 0.56 | 0.54 | 0.54 | |
Share Based Compensation of Revenue |
1.45% | 1.05% | 0.81% | 0.86% | |
Graham Net Nets |
(0.05) | (0.05) | (0.05) | (0.05) | |
Graham Number |
105.94 | 108.67 | 114.57 | 116.91 | |
Earnings Yield |
2.82% | 2.84% | 3.60% | 3.90% | |
Free Cash Flow Yield |
3.99% | 3.76% | 4.53% | 4.55% | |
Revenue per Share |
14.84 | 15.24 | 16.17 | 15.29 | |
Operating CF per Share |
2.92 | 3.04 | 3.42 | 3.76 | |
Capex per Share |
(0.88) | (0.90) | (0.92) | (0.90) | |
Free Cash Flow per Share |
2.04 | 2.14 | 2.50 | 2.86 | |
Cash per Share |
3.24 | 4.31 | 4.48 | 4.94 | |
Shareholders Equity per Share |
71.37 | 72.99 | 73.29 | 73.99 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
71.37 | 72.99 | 73.29 | 73.99 | |
Free Cash Flow |
201.20 | 209.90 | 245.30 | 279.60 | |
Working Capital |
1,217.40 | 1,363.90 | 1,249.60 | 1,162.50 | |
Capital Expenditures |
(86.60) | (88.30) | (90.10) | (87.50) | |
Net Current Asset Value |
(1,281.90) | (1,137.30) | (1,145.40) | (1,069.00) | |
EV/EBIT |
26.77 | 26.46 | 21.06 | 19.24 | |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.06 | |
Price to Operating Income |
25.02 | 24.87 | 19.71 | 18.00 | |
| Other line items | |||||
Average Receivables |
935.32 | 952.90 | 1,068.40 | 980.15 | |
Average Payables |
271.99 | 261.70 | 309.80 | 322.50 | |
Average Inventory |
673.72 | 661.53 | 606.55 | 676.65 | |
Average Assets |
10,326.42 | 10,299.88 | 10,442.00 | 10,570.55 | |
Average Common Equity |
6,816.48 | 6,798.22 | 6,906.55 | 7,095.55 |
Columns are period end dates